Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03052166 · ClinicalTrials.gov registry record
Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging
A clinical trial, sponsored by QT Ultrasound.
- Completed
- Registry status
- 755
- Enrollment target
NCT03052166: Completed study, sponsored by QT Ultrasound.
NCT03052166 is a clinical trial that has completed, run by QT Ultrasound. The registered enrollment target is 755 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03052166 has completed, sponsored by QT Ultrasound.
- COMPLETED
- Registry status
- 755 participants
- Enrollment target
Study Summary
Brief Summary: The QT Ultrasound system is an automated scanner which transmits pulsed ultrasound plane waves through the breast, as well as collects reflected ultrasound output. As the patient lays prone on a table, the breast is submerged in a warm water bath. The transmitter and receiver assembly moves around the suspended breast to record data for successive sub-volumes of targeted tissue. More than 2000 elements in the curvilinear transducer's array encircle the breast to gather data from the tissue structures of the breast, from nipple to chest wall. Information gathered from this automated QT scan encompasses the entire breast which is currently not commercially available using any other ultrasound technology.
Primary Outcome
Non-inferiority evaluation of sensitivity, specificity, positive predictive value and non-cancer recall rate.
Interventions
- DEVICE QT Ultrasound scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 755 participants |
| Start Date | 2017-04-18 |
| Est. Completion | 2020-01-01 |
What the finished NCT03052166 record still lists
NCT03052166 is an observational study that tracks outcomes without assigning an intervention. The registered 755 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which QT Ultrasound scan is the first listed.
NCT03052166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03052166 about?
NCT03052166 is a clinical study titled "Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging". Brief Summary: The QT Ultrasound system is an automated scanner which transmits pulsed ultrasound plane waves through the breast, as well as collects reflected ultrasound output. As the patient lays prone on a table, the breast is submerged in a warm water bath. The transmitter and receiver assembly...
What is the current status of trial NCT03052166?
This trial is currently completed. The enrollment target is 755 participants. The study started on 2017-04-18. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03052166?
The interventions under investigation include: QT Ultrasound scan (DEVICE).
Who is sponsoring clinical trial NCT03052166?
This trial is sponsored by QT Ultrasound, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI